CAS 1431368-48-7

GSK-LSD1

CAS : 1431368-48-7

GSK-LSD1 is an LSD1 inhibitor that regulates the cell cycle and induces apoptosis, and can be used for the study of breast cancer.

Formule : C₁₄H₂₀N₂

Degré de pureté : 99.59%

Couleur et forme : Solid

Masse moléculaire : 216.32

Ref: TM-T82254

GSK-LSD1

CAS : 1431368-48-7

GSK-LSD1

Degré de pureté : ≥98%

Masse moléculaire : 216.32g/mol

Ref: 54-BUP01590

GSK LSD1 Dihydrochloride-d4

Produit contrôlé

CAS : 1431368-48-7

Formule : C₁₄H₁₈D₄Cl₂N₂

Couleur et forme : Neat

Masse moléculaire : 220.347

Ref: TR-G797572

GSK LSD1 Dihydrochloride-d4

CAS : 1431368-48-7

GSK LSD1 Dihydrochloride-d4 is a chemical inhibitor that binds to the active site of the enzyme lactate dehydrogenase (LDH) and prevents its activity. LDH is an enzyme that converts pyruvate to lactate, which is then used as an energy source in cells. GSK LSD1 Dihydrochloride-d4 has been shown to inhibit the proliferation of Thp-1 cells induced by inflammatory bowel disease or all-trans retinoic acid, which are used for leukemic research. The LDH inhibition leads to decreased autophagy and cell death in vitro and in vivo. GSK LSD1 Dihydrochloride-d4 has also been shown to be less toxic than other chemical inhibitors when administered orally to leukemia mice.

Formule : C₁₄H₁₈D₄Cl₂N₂

Degré de pureté : Min. 95%

Masse moléculaire : 293.27 g/mol

Ref: 3D-GHC36848